about
Quantitative EEG and Cognitive Decline in Parkinson's DiseaseDissection of the internal carotid artery mimicking episodic cluster headacheReproducibility of functional connectivity and graph measures based on the phase lag index (PLI) and weighted phase lag index (wPLI) derived from high resolution EEG.Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.Slowing of EEG background activity in Parkinson's and Alzheimer's disease with early cognitive dysfunctionPower spectra for screening parkinsonian patients for mild cognitive impairmentMicrostate connectivity alterations in patients with early Alzheimer's disease.Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis.Superficial brain stimulation in multiple sclerosis.Reliability of Functional Connectivity of Electroencephalography Applying Microstate-Segmented Versus Classical Calculation of Phase Lag Index.Reliability of fully automated versus visually controlled pre- and post-processing of resting-state EEG.Clinical evoked potentials in neurology: a review of techniques and indications.Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease.Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome.Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.Re: Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.Correlation of EEG slowing with cognitive domains in nondemented patients with Parkinson's disease.Vertebral artery dissection presenting with fifth cervical root (C5) radiculopathyMulticentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trials[Agitation and gamma-hydroxybutyrate]
P50
Q26752409-1E450F1A-2D96-4865-AD9C-86C369F3803CQ28219833-AC1EE189-9870-4571-8AC7-394FBD406F30Q34293994-D83D3272-7744-4780-9044-AF1F24D49223Q34359497-28EF746A-AC89-4B4F-9D5D-570354B8FADAQ34531520-FB771BF2-217C-47A0-A895-3459E08FD175Q34692039-E4037520-A799-4D9C-A673-B98BB0E8B252Q36419603-5A01E8C0-00C0-4714-B64A-B4222161B2B4Q37231656-150A5C5F-BAB3-4FE8-8FE2-7BA7521E35E9Q38151354-5629557F-25CA-4B09-84D4-87D76332928BQ39056567-AD35B6C2-9198-44D4-B999-0BC8CCFFAE2AQ39056585-3E4E1966-D8EA-4354-9AE4-B2A9070666E9Q39149947-B486BE83-5339-4D24-8513-9279FD788D1EQ39399332-4333540E-9530-4A28-824F-1039CEC4EBDAQ39436496-EB1423B5-4C5C-4862-AE04-A6B353B0D5C8Q41369774-E71D4F56-163B-42CF-B2AE-3ED1DA200E6DQ41473773-C4E35AF9-4EE6-4637-8226-ADFDF11E2C27Q45396892-EAEA7E68-AB6A-4FC0-A4B3-A92859931745Q46740274-11C2E73B-B012-45EF-A617-B17E5C6C379BQ48091834-2FCDDCCB-CBF2-4BD9-A4EF-D50467F8CC3DQ48174782-685BF43C-EA01-4D83-BA4A-91A72531834FQ48953267-05C48014-325E-448C-B6A1-B64F10A11E7EQ49117984-2433057C-8B06-4526-9339-BF0BC7FCDAFBQ50758144-6EDA75CE-FFC3-42DA-A879-187B4D96875EQ57542145-B2839862-58F7-4993-BFE3-F132EAF77A28Q64076206-617471F8-3F6D-43D0-9B61-11E68A10C32FQ80218461-3275B546-2D18-4C74-8961-DAFD92889F96
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martin Hardmeier
@ast
Martin Hardmeier
@en
Martin Hardmeier
@es
Martin Hardmeier
@nl
Martin Hardmeier
@sl
type
label
Martin Hardmeier
@ast
Martin Hardmeier
@en
Martin Hardmeier
@es
Martin Hardmeier
@nl
Martin Hardmeier
@sl
prefLabel
Martin Hardmeier
@ast
Martin Hardmeier
@en
Martin Hardmeier
@es
Martin Hardmeier
@nl
Martin Hardmeier
@sl
P106
P31
P496
0000-0003-1451-7337